Market Cap

Haleon plc Market Capitalization:

£29.50 Billion

GBP as of July 1, 2024

US$37.32 Billion

business Haleon plc Company Profile

Haleon plc Main Stock Listing

LSE: HLN

Market Capitalization History of Haleon plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Teva Pharmaceutical Industries Limited $18.88 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Haleon plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £30.55 B 5.97%
Jan. 1, 2023 £28.83 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Company Description

Haleon plc, headquartered in Brentford, UK, specializes in the R&D, manufacture, and sale of consumer healthcare products across various regions. Their offerings encompass therapeutic oral health, pain relief, respiratory, digestive products, and vitamins and supplements. Key brands include Panadol, Voltaren, Advil, Sensodyne, and Centrum.

business Haleon plc Company Profile

Haleon plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—Specialty & Generic
United Kingdom Healthcare United Kingdom Drug Manufacturers—Specialty & Generic

Stocks & Indices

Haleon plc has the following listings and related stock indices.


Stock: LSE: HLN

Stock: NYSE: HLN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.